Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo

Mol Biol (Mosk). 2022 Nov-Dec;56(6):884-891. doi: 10.31857/S002689842206012X.

NO ABSTRACT